Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, ...

Clinically meaningful activity was observed in 57 patients at 400 mg BID fed, including 11.1-month median PFS and mutation-subtype–agnostic benefit across kinase versus nonkinase PIK3CA variants.

The Company will issue a release after the oral presentation that will include the 5-year OS data, which is the longest OS ...

Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Just in time for St. Patrick's Day, discover why four-leaf clovers are lucky, the folklore behind the legend, how rare they ...

Forget bedbugs and cockroaches — NYC is battling “superbugs” that can’t easily be quashed. Candida auris, for one, survives ...

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of ...

The former Strictly Come Dancing contestant underwent preventative surgery after testing positive for the BRCA mutation ...

Breast cancer isn't just a 'pink' disease; for men with a family history or genetic predisposition, a mammogram can be a ...

The tiny Amazon molly (Poecilia formosa) has always fascinated researchers because, according to the rules of evolution, it ...